IQVIA Holdings Inc. Stock News

Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.

IQVIA Holdings Inc (IQV) shares closed today at 0.5% below its 52 week high of $283.57, giving the company a market cap of $53B. The stock is currently up 56.6% year-to-date, up 60.1% over the past 12 months, and up 269.4% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 52.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -482.3% The company's stock price performance over the past 12 months beats the peer average by -470.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1145.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Jared Holz, Oppenheimer healthcare strategist, joins 'Power Lunch' to discuss the healthcare sector and why biotech companies could struggle the most in the space. For access to live and exclusive vid

IQVIA Holdings Inc (IQV) shares closed today at 0.6% below its 52 week high of $279.68, giving the company a market cap of $53B. The stock is currently up 55.2% year-to-date, up 58.0% over the past 12 months, and up 264.7% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 1.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -479.3% The company's stock price performance over the past 12 months beats the peer average by -475.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1200.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

IQVIA Holdings Inc (IQV) shares closed today at 0.6% below its 52 week high of $279.68, giving the company a market cap of $53B. The stock is currently up 55.2% year-to-date, up 58.0% over the past 12 months, and up 264.7% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 0.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -479.3% The company's stock price performance over the past 12 months beats the peer average by -475.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1200.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

IQVIA Holdings Inc (IQV) shares closed today at 0.6% below its 52 week high of $279.68, giving the company a market cap of $53B. The stock is currently up 55.2% year-to-date, up 58.4% over the past 12 months, and up 264.7% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 0.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -479.3% The company's stock price performance over the past 12 months beats the peer average by -493.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 1200.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

IQVIA (NYSE:IQV) had its price target increased by Mizuho from $290.00 to $300.00 in a research report released on Monday, Analyst Ratings Network reports. They currently have a buy rating on the medical research companys stock. IQV has been the topic of a number of other research reports. Morgan Stanley boosted their target price on []

IQVIA Holdings Inc. (NYSE:IQV) saw a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 2,350,000 shares, a growth of 19.3% from the November 15th total of 1,970,000 shares. Based on an average daily volume of 773,200 shares, the days-to-cover ratio is currently 3.0 days. []

Cutter & CO Brokerage Inc. grew its position in IQVIA Holdings Inc. (NYSE:IQV) by 1.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,680 shares of the medical research companys stock after purchasing an additional 56 shares during the quarter. Cutter & CO []

Goelzer Investment Management Inc. trimmed its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 20.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 35,655 shares of the medical research companys stock after selling 9,255 shares during the period. Goelzer Investment Management Inc.s []

IQVIA Holdings with ticker code (IQV) have now 18 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 320 and 261 with a mean TP of 300.22. Given that the stocks previous close was at 262.65 this would indicate that there is a potential upside of 14.3%. The 50 day MA is 256.57 while the 200 day moving average is 239.9. The market cap for the company is $51,218m. Visit the company website at: https://www.iqvia.com [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients'' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

Equities research analysts expect that IQVIA Holdings Inc. (NYSE:IQV) will post earnings of $2.43 per share for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for IQVIAs earnings, with the highest EPS estimate coming in at $2.47 and the lowest estimate coming in at $2.40. IQVIA reported earnings per share of $2.11 []

Adams Diversified Equity Fund Inc. trimmed its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 11.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 79,700 shares of the medical research company’s stock after selling 10,300 shares during the period. Adams […]

Park Avenue Securities LLC grew its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 7.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,000 shares of the medical research companys stock after acquiring an additional 213 shares during the quarter. Park Avenue Securities []

Gateway Investment Advisers LLC reduced its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 3.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,120 shares of the medical research companys stock after selling 44 shares during the period. []